Avaxia Biologics Secures $1,243,378 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=38e20fa9-fb23-4094-a11f-d2456ef2af5a&Preview=1
Date
1/9/2012
Company Name
Avaxia Biologics
Mailing Address
128 Spring Street Lexington, MA 02421
Company Description
Avaxia is developing oral antibody products for diseases and disease targets that can be reached through the mouth and the gastrointestinal tract.
Website
http://www.avaxiabiologics.com
Transaction Type
Venture Equity
Transaction Amount
$1,243,378
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing-amended.
M&A Terms
Venture Investor
Undisclosed